Peripherally Inserted Central Catheter (PICC) market size was valued at USD 1.83 Billion in 2022 and is projected to reach USD 4.76 Billion by 2030, growing at a CAGR of 12.6% from 2024 to 2030. The demand for PICC lines has been increasing due to their wide usage in delivering intravenous medications, fluids, and nutritional support in hospital and outpatient settings. The growing prevalence of chronic diseases, cancer, and geriatric populations needing long-term intravenous therapy is significantly driving the market growth. Furthermore, the rise in minimally invasive procedures and increasing healthcare spending is expected to boost the adoption of these catheters in clinical settings.The market is also driven by the advancements in PICC technology, including the introduction of better materials for catheter construction, which reduce the risk of infection and improve patient outcomes. Additionally, the increase in outpatient procedures, coupled with rising awareness regarding the benefits of PICC lines over traditional central venous catheters, is creating substantial market opportunities. The North American region leads the market due to its well-established healthcare infrastructure, while the Asia Pacific region is expected to grow at the highest rate during the forecast period due to improving healthcare access and rising healthcare investments.
Download Full PDF Sample Copy of Market Report @
Peripherally Inserted Central Catheter Market Research Sample Report
The Peripherally Inserted Central Catheter (PICC) market by application is segmented primarily into three main categories: Hospitals, Outpatient Surgery Centres, and Catheterization Laboratories. This segmentation reflects the broad and diverse usage of PICC devices in various healthcare settings, driven by the need for long-term venous access for patients requiring intravenous therapy, chemotherapy, and nutrition. Understanding the market trends and demand across these subsegments is essential to navigating the overall growth prospects of the PICC market.
Hospitals represent the largest segment in the PICC market, driven by the high demand for long-term venous access for critically ill patients. These facilities often provide comprehensive care for patients who need prolonged intravenous treatments, such as those undergoing chemotherapy, long-term antibiotic therapy, or total parenteral nutrition. The ability to insert a PICC catheter safely and reliably allows hospitals to manage patients with complex needs, reducing the risks of complications compared to other central venous access devices. Hospitals offer the necessary infrastructure, medical expertise, and continuous monitoring required for PICC insertion and maintenance, which is a key factor in the high adoption of PICC devices in these settings.
Moreover, hospitals have been increasingly focusing on minimizing hospital-acquired infections (HAIs) and complications related to central venous access. As such, there has been a growing trend toward using PICC lines as they provide a lower risk of infection and thrombosis compared to other central lines, such as the non-peripherally inserted central catheters (CVCs). The ongoing improvement in catheter technologies, including the introduction of antimicrobial-coated PICCs, is expected to further boost their use in hospitals. As hospitals remain the primary setting for the treatment of high-acuity patients, the PICC market in this segment is expected to continue its steady growth, driven by both patient needs and technological advancements in catheter design and insertion techniques.
Outpatient surgery centres are increasingly adopting Peripherally Inserted Central Catheters due to the rising trend of performing more complex procedures on an outpatient basis. These centres are equipped to handle surgical procedures that require post-operative intravenous therapy, such as long-term antibiotics, pain management, or intravenous nutrition. PICCs are an attractive option in these settings because they provide a safer and more comfortable long-term access route for patients who do not require inpatient care. The use of PICCs in outpatient surgery centres has become more prevalent due to their minimally invasive insertion process and the shorter recovery times compared to traditional central venous access devices.
Additionally, the cost-effectiveness of PICCs in outpatient surgery centres is an important factor contributing to their growth in this segment. These centres often cater to patients with less severe conditions or those undergoing elective procedures, making it critical to ensure efficient management of intravenous therapy without incurring excessive costs. The growing demand for outpatient procedures and the increased focus on reducing healthcare costs have led to the expansion of PICC usage in these settings. With advancements in catheter design and the availability of specialized insertion equipment, outpatient surgery centres are expected to continue adopting PICCs as a safe and effective solution for intravenous access during and after surgery.
Catheterization laboratories, or cath labs, are specialized areas within hospitals designed for minimally invasive procedures, including the placement of central venous access devices like PICCs. These labs are equipped with advanced imaging technology that aids in the precise insertion of PICCs, making them an ideal environment for their use. The increasing demand for catheter-based interventions, such as angioplasty and electrophysiological studies, has driven the need for reliable venous access systems, and PICCs offer a long-term, low-risk solution for these procedures. The presence of specialized medical personnel, including interventional radiologists and cardiologists, ensures that PICC insertions are performed with high precision and minimal complications.
Furthermore, catheterization laboratories are pivotal in the treatment of patients with cardiovascular conditions who often require long-term medication and therapy. The use of PICC lines in these procedures offers the benefit of reduced complications compared to traditional methods like jugular or subclavian central venous catheters. As more catheterization laboratories adopt advanced PICC insertion techniques, the market for these devices in cath labs is poised for growth. The growing focus on improving patient outcomes and reducing procedure-related risks in specialized settings will further boost the use of PICC devices in catheterization laboratories.
The Peripherally Inserted Central Catheter (PICC) market is experiencing several key trends that indicate positive growth prospects in the coming years. One major trend is the continuous improvement in the materials and designs used in PICC devices, leading to increased patient safety and reduced complication rates. For instance, the development of antimicrobial-coated PICCs helps minimize the risk of infection, which is one of the leading concerns associated with central venous access. Additionally, advancements in ultrasound-guided insertion techniques have enhanced the accuracy of PICC placement, reducing the risks of complications and increasing the success rates of catheter insertions.
Another important trend is the growing preference for minimally invasive procedures, which has encouraged the use of PICCs over traditional central venous access devices. The increasing emphasis on outpatient care and same-day discharge policies also supports the adoption of PICCs, as they provide a safe and efficient means of intravenous access for patients who do not require prolonged hospitalization. Furthermore, the rise of home healthcare services has created new opportunities for the PICC market, as patients undergoing chemotherapy or long-term antibiotic treatments can receive intravenous therapy in the comfort of their homes, reducing the strain on hospitals and healthcare systems. These trends, combined with the increasing demand for PICC devices in various healthcare settings, present significant growth opportunities for manufacturers and healthcare providers in the PICC market.
1. What is a Peripherally Inserted Central Catheter (PICC)?
A PICC is a type of central venous catheter inserted through a peripheral vein, typically in the arm, to provide long-term intravenous access for patients requiring treatments like chemotherapy or antibiotics.
2. Why are PICC lines preferred over traditional central venous catheters?
PICC lines are preferred due to their lower risk of infection, ease of insertion, and reduced complications compared to traditional central venous catheters like jugular or subclavian lines.
3. How long can a PICC line stay in place?
A PICC line can remain in place for weeks to months, depending on the patient’s condition and the type of therapy being administered, under proper medical supervision.
4. What are the common risks associated with PICC lines?
Common risks include infection, blood clots, catheter migration, and thrombophlebitis, but these risks can be minimized with proper care and regular monitoring.
5. Can PICC lines be used in outpatient settings?
Yes, PICC lines are commonly used in outpatient settings, such as outpatient surgery centres, for patients requiring long-term intravenous therapy without the need for inpatient care.
6. What is the role of ultrasound in PICC insertion?
Ultrasound guidance is used to improve the accuracy of PICC insertion, helping healthcare providers visualize veins and reduce the risk of complications during the procedure.
7. Are PICC lines safe for pediatric patients?
PICC lines are safe for pediatric patients, especially when inserted by experienced medical professionals, and are commonly used for pediatric oncology, nutrition, and antibiotic therapies.
8. How does a PICC line differ from a central venous catheter?
A PICC is inserted through a peripheral vein and threaded to the central veins, while a traditional central venous catheter is typically inserted directly into a central vein, such as the jugular or subclavian vein.
9. How is the risk of infection minimized with PICC lines?
The risk of infection can be minimized by using sterile techniques during insertion, employing antimicrobial-coated PICC lines, and following proper care protocols throughout the catheter's use.
10. Can PICC lines be used for chemotherapy?
Yes, PICC lines are commonly used for chemotherapy as they provide reliable and long-term intravenous access, minimizing the need for frequent needle sticks.
For More Information or Query, Visit @ Peripherally Inserted Central Catheter Market Size And Forecast 2025-2030